162 related articles for article (PubMed ID: 21857112)
1. Proteomic identification of CIB1 as a potential diagnostic factor in hepatocellular carcinoma.
Junrong T; Huancheng Z; Feng H; Yi G; Xiaoqin Y; Zhengmao L; Hong Z; Jianying Z; Yin W; Yuanhang H; Jianlin Z; Longhua S; Guolin H
J Biosci; 2011 Sep; 36(4):659-68. PubMed ID: 21857112
[TBL] [Abstract][Full Text] [Related]
2. Serum and tissue proteomic signatures of patients with hepatocellular carcinoma using 2‑D gel electrophoresis.
Peng H; Yan Z; Zeng X; Zhang S; Jiang H; Huang H; Zhuo H
Mol Med Rep; 2019 Aug; 20(2):1025-1038. PubMed ID: 31173207
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma.
Gou L; Wang W; Tong A; Yao Y; Zhou Y; Yi C; Yang J
J Mol Med (Berl); 2011 Aug; 89(8):817-27. PubMed ID: 21475975
[TBL] [Abstract][Full Text] [Related]
4. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
5. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
Tan GS; Lim KH; Tan HT; Khoo ML; Tan SH; Toh HC; Ching Ming Chung M
J Proteome Res; 2014 Nov; 13(11):4833-46. PubMed ID: 24946162
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.
Ren F; Wu H; Lei Y; Zhang H; Liu R; Zhao Y; Chen X; Zeng D; Tong A; Chen L; Wei Y; Huang C
Mol Cancer; 2010 Apr; 9():81. PubMed ID: 20403181
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
9. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.
Sun W; Xing B; Sun Y; Du X; Lu M; Hao C; Lu Z; Mi W; Wu S; Wei H; Gao X; Zhu Y; Jiang Y; Qian X; He F
Mol Cell Proteomics; 2007 Oct; 6(10):1798-808. PubMed ID: 17627933
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Int J Mol Sci; 2010 Mar; 11(4):1423-33. PubMed ID: 20480028
[TBL] [Abstract][Full Text] [Related]
11. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.
Wang Y; He D; Yang L; Wen B; Dai J; Zhang Q; Kang J; He W; Ding Q; He D
Biochem Biophys Res Commun; 2015 Jul; 463(3):458-65. PubMed ID: 26043685
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
13. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q
Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
[TBL] [Abstract][Full Text] [Related]
16. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis.
Molee P; Adisakwattana P; Reamtong O; Petmitr S; Sricharunrat T; Suwandittakul N; Chaisri U
Int J Clin Exp Pathol; 2015; 8(9):9796-811. PubMed ID: 26617690
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.
Guo Y; Zhao J; Bi J; Wu Q; Wang X; Lai Q
J Hematol Oncol; 2012 Jul; 5():37. PubMed ID: 22760167
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the
Zhang J; Ma H; Yang L; Yang H; He Z
J Int Med Res; 2019 Mar; 47(3):1319-1329. PubMed ID: 30678511
[TBL] [Abstract][Full Text] [Related]
20. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]